Pathology of Ischemic Stroke
Ischemic stroke results from cerebral blood flow interruption causing a cascade of cellular injury through five primary pathophysiological mechanisms: excitotoxicity, oxidative stress, inflammation, blood-brain barrier disruption, and cell death—with the specific pathological pattern determined by the stroke subtype and vascular territory involved.
Classification by Pathological Mechanism
The pathology of ischemic stroke is best understood through the TOAST classification system, which categorizes strokes into five distinct pathological subtypes 1, 2, 3:
1. Large-Artery Atherosclerosis
- Vascular pathology: Luminal occlusion or ≥50% stenosis of major cerebral arteries from atherosclerotic plaque
- Infarct pattern: Cortical infarction in large vessel distribution
- Mechanism: Artery-to-artery embolism or hemodynamic insufficiency
- Location: Extracranial or intracranial major vessels (carotid, vertebral, basilar, circle of Willis)
2. Cardioembolism
- Vascular pathology: Arterial occlusion from cardiac-origin thrombus
- Infarct pattern: Cortical or large subcortical infarctions
- Source: High-risk cardiac conditions (atrial fibrillation, valvular disease, recent MI)
- Key feature: Absence of parent artery atherosclerotic narrowing
3. Small-Artery (Lacunar) Stroke
- Vascular pathology: Occlusive arteriopathy of small penetrating vessels (<1.5 cm lesions)
- Location: Deep brain structures or brainstem
- Mechanism: NOT atherosclerotic—associated with chronic hypertension and diabetes
- Clinical pattern: Lacunar syndromes (pure motor hemiparesis, pure sensory stroke)
- Prognosis: Best survival among stroke subtypes (86% 5-year survival) 2
4. Uncommon Causes
- Nonatherosclerotic vasculopathies
- Hypercoagulable states
- Hematologic disorders
- No restriction on infarct size or location
5. Undetermined Cause
- Represents >33% of all strokes 1, 2
- Multiple potential mechanisms identified
- Incomplete diagnostic evaluation
Cellular and Molecular Pathophysiology
Ischemic Cascade
When cerebral blood flow drops below critical thresholds, a stereotyped sequence of pathological events unfolds 4, 5, 6:
Immediate Phase (Minutes)
- Oxygen and glucose deprivation
- ATP depletion and energy failure
- Ion pump failure with sodium/calcium influx
- Cellular depolarization
Early Phase (Hours)
- Excitotoxicity: Glutamate release causing calcium overload via NMDA receptors
- Oxidative stress: Mitochondrial dysfunction generating reactive oxygen species (superoxide, peroxynitrite, hydroxyl radicals)
- Mitochondrial damage: Electron transport chain disruption, cytochrome c release
Subacute Phase (Days)
- Inflammation: NLRP3 inflammasome activation, IL-1β release, microglial activation
- Blood-brain barrier disruption: Endothelial damage, vasogenic edema
- Cell death: Apoptosis in penumbra, necrosis in core
Reperfusion Injury Pathology
Restoration of blood flow paradoxically amplifies injury through 4, 7:
- Massive ROS generation from reoxygenation
- Neutrophil infiltration and cytokine storm
- Secondary infarction expansion
- Hemorrhagic transformation risk
Tissue Pathology Patterns
Infarct Core
- Irreversible neuronal necrosis
- Complete loss of cellular architecture
- Occurs within minutes of severe ischemia
Ischemic Penumbra
- Functionally impaired but structurally intact tissue
- Salvageable with timely reperfusion
- Shows apoptotic cell death patterns
- Target zone for therapeutic intervention
White Matter Vulnerability
- Particularly susceptible to chronic hypoperfusion
- Oligodendrocyte death and demyelination
- Contributes to vascular cognitive impairment 8, 9
Prognostic Implications by Pathological Subtype
Stroke subtype strongly predicts mortality and cardiac risk 2:
- Cardioembolic: Highest mortality (22.6% at 90 days, 55% 2-year survival)
- Large-artery atherosclerosis: Intermediate mortality, highest cardiac event risk (50% abnormal cardiac stress tests)
- Small-vessel disease: Lowest mortality (3.3% at 90 days, 85% 2-year survival), lowest cardiac risk
Clinical Correlation
Common Pitfall: Over one-third of strokes remain pathologically unclassified despite complete workup, reflecting the complexity of cerebrovascular pathology and frequent coexistence of multiple mechanisms 1, 2. This underscores the importance of comprehensive vascular imaging and cardiac evaluation to guide secondary prevention strategies.
The pathological heterogeneity of ischemic stroke—ranging from atherosclerotic large vessel disease to small vessel lipohyalinosis to cardiac embolism—demands subtype-specific diagnostic approaches and therapeutic strategies, as each carries distinct recurrence risks and requires tailored prevention measures 3, 10.